Clinical and Translational Research of Urological Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 7
Special Issue Editors
Interests: urological cancer and surgery
2. Department of urology, Humanitas Gavazzeni, Bergamo, Italy
Interests: bladder cancer; urothelial cancer; conservative treatment; immunotherapy; radical cystectomy; robotic surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is our pleasure to invite you to collaborate on this Special Issue, ‘Clinical and Translational Research of Urological Cancer’.
The field of urological cancer is constantly evolving with new technologies, new therapeutic agents, and biomarkers with better perspectives for patients and urologists.
The aim of this Issue is to give a panoramic view of the novelties and most recent, relevant evidence in the field of clinical and translational research of urological cancers, from the application of artifical intelligence to predict oncological outcomes to the new biomarkers and promising immunotherapy that have completely changed how urological cancers are managed.
Original studies and reviews are more than welcome for this Issue to help increase our knowledge in the wide field of urological cancers.
We look forward to receiving your contributions.
Dr. Mauro Ragonese
Dr. Luca Di Gianfrancesco
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urological cancer
- bladder cancer
- surgery
- conservative treatment
- immunotherapy
- radical cystectomy
- artifical intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
